Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 2555-2560

  Terryn, Wim ^a   Deschoenmakere, Gert ^b   De Keyser, Jan ^a   Meersseman, Wouter ^c   Van Biesen, Wim ^d   Wuyts, Brigitte ^d   Hemelsoet, Dimitri ^d   Pascale, Hilbert ^e   De Backer, Julie ^d   De Paepe, An ^d   Poppe, Bruce ^d   Vanholder, Raymond ^a,d  

^a Department of Nephrology   (Belgium)

^b Heilig Hart Ziekenhuis   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e INSTITUTE OF PATHOLOGY AND GENETICS   (Belgium)

Author keywords

Fabry disease; Hypertension; Left ventricular hypertrophy; Screening

Indexed keywords

ADENINE; ALANINE; ALPHA GALACTOSIDASE; CYTOSINE; GLUTAMIC ACID;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; DRIED BLOOD SPOT TESTING; ENZYME ACTIVITY; FABRY DISEASE; FEMALE; GENE MUTATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SCREENING;

FABRY DISEASE; HYPERTENSION; LEFT VENTRICULAR HYPERTROPHY; SCREENING;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-GALACTOSIDASE; DNA MUTATIONAL ANALYSIS; DRIED BLOOD SPOT TESTING; FABRY DISEASE; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PEDIGREE; PREVALENCE; YOUNG ADULT;

EID: 84883811102     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.06.069     Document Type: Article

References (31)

1. S.R. Ommen, R.A. Nishimura, and W.D. Edwards Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy? Heart 89 8 2003 929 930
2. J.C. Wu, C.Y. Ho, and H. Skali Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and -galactosidase A activity Eur Heart J 31 9 2010 1088 1097
3. A. Linhart, C. Kampmann, and J.L. Zamorano Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey Eur Heart J 28 10 2007 1228 1235
4. M. Beck, R. Ricci, and U. Widmer Fabry disease: overall effects of agalsidase alfa treatment Eur J Clin Invest 34 12 2004 838 844
5. D.A. Hughes, P.M. Elliott, and J. Shah Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa Heart 94 2 2008 153 158
6. A. Mehta, M. Beck, and P. Elliott Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data Lancet 374 9706 2009 1986 1996
7. S. Nakao, T. Takenaka, and M. Maeda An atypical variant of Fabry's disease in men with left ventricular hypertrophy N Engl J Med 333 5 1995 288 293
8. B. Sachdev Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy Circulation 105 12 2002 1407 1411
9. C. Chimenti Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy Circulation 110 9 2004 1047 1053
10. M. Arad, B.J. Maron, and J.M. Gorham Glycogen storage diseases presenting as hypertrophic cardiomyopathy N Engl J Med 352 4 2005 362 372
11. L. Monserrat, J.R. Gimeno-Blanes, and F. Marín Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy J Am Coll Cardiol 50 25 2007 2399 2403
12. A.A. Hagege, E. Caudron, and T. Damy Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study Heart 97 2 2010 131 136
13. O. Havndrup, M. Christiansen, and B. Stoevring Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women Eur J Heart Fail 12 6 2010 535 540
14. P. Elliott, R. Baker, and F. Pasquale Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey Heart 97 23 2011 1957 1960
15. J. Kleinert, F. Dehout, and A. Schwarting Prevalence of uncontrolled hypertension in patients with Fabry disease Am J Hypertens 19 8 2006 782 787
16. A. Ortiz, J.P. Oliveira, and S. Waldek Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy Nephrol Dial Transplant 23 5 2008 1600 1607
17. G.E. Linthorst, A.C. Vedder, J.M.F.G. Aerts, and C.E.M. Hollak Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers Clin Chim Acta 353 1-2 2005 201 203
18. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification Eur J Echocardiogr 7 2 2006 79 108
19. N.A. Chamoles, M. Blanco, and D. Gaggioli Fabry disease: enzymatic diagnosis in dried blood spots on filter paper Clin Chim Acta 308 1-2 2001 195 196
20. J.K. Ploos van Amstel, R.P. Jansen, J.G. de Jong, B.C. Hamel, and R.A. Wevers Six novel mutations in the alpha-galactosidase A gene in families with Fabry disease Hum Mol Genet 3 3 1994 503 505
21. C.S. Nance, C.J. Klein, and M. Banikazemi Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome Arch Neurol 63 3 2006 453 457
22. T.P. Mechtler, S. Stary, and T.F. Metz Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria Lancet 379 9813 2012 335 341
23. P.J. Meikle, J.J. Hopwood, A.E. Clague, and W.F. Carey Prevalence of lysosomal storage disorders JAMA 281 3 1999 249 254
24. G.E. Linthorst, M.G. Bouwman, F.A. Wijburg, J.M.F.G. Aerts, B.J.H.M. Poorthuis, and C.E.M. Hollak Screening for Fabry disease in high-risk populations: a systematic review J Med Genet 47 4 2010 217 222
25. M. Spada, S. Pagliardini, and M. Yasuda High incidence of later-onset fabry disease revealed by newborn screening Am J Hum Genet 79 1 2006 31 40
26. W.-L. Hwu, Y.-H. Chien, and N.-C. Lee Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) Hum Mutat 30 10 2009 1397 1405
27. C. Kampmann, A. Linhart, and F. Baehner Onset and progression of the Anderson-Fabry disease related cardiomyopathy Int J Cardiol 130 3 2008 367 373
28. M.R. Patel, F. Cecchi, and M. Cizmarik Cardiovascular events in patients with Fabry disease J Am Coll Cardiol 57 9 2011 1093 1099
29. A. Gal, D.A. Hughes, and B. Winchester Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group J Inherit Metab Dis 34 2 2011 509 514
30. A. Linhart, and P.M. Elliott The heart in Anderson-Fabry disease and other lysosomal storage disorders Heart 93 4 2007 528 535
31. J. Andrade, P.J. Waters, and R.S. Singh Screening for Fabry disease in patients with chronic kidney disease: limitations of plasma alpha-galactosidase assay as a screening test Clin J Am Soc Nephrol 3 1 2008 139 145